Results Propanc Biopharma Inc.
-
Scientific Whitepaper (Story board 2019 DEF)
-6h 6m
-
Fact Sheet (Propanc Biopharma Investor Fact Sheet 2023)
-6h 7m
-
Investor Presentation (Propanc Biopharma Corporate Presentation)
-6h 7m
-
Antitumour efficacy of chymotrypsinogen and trypsinogen
-6h 27m
-
Blocking Tumor Support from Cancer-Associated Fibroblasts in Tumor Microenvironment
-6h 27m
-
Supplemental Prospectus (Form 424B3)
8/18
-
Supplemental Prospectus (Form 424B4)
8/18
-
Listing Approval Certification by Exchange (Form CERT)
8/14
-
Notice of Effectiveness (Form EFFECT)
8/14
-
New Listing Registration (Form 8-A12B)
8/13